BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
Category: Business
Eyenuk annonce l'autorisation de la FDA pour le système autonome EyeArt pour le dépistage de la rétinopathie diabétique
LOS ANGELES–(BUSINESS WIRE)–Eyenuk, Inc., une société mondiale de technologie et de services médicaux basés sur l’intelligence artificielle (IA) et le leader des applications en situation réelle pour le dépistage des troubles de la vue basé sur l’IA,…
Eyenuk anuncia autorização da FDA para o sistema de IA autônoma EyeArt para triagem de retinopatia diabética
LOS ANGELES–(BUSINESS WIRE)–Eyenuk, Inc., uma empresa global de serviços e tecnologia médica de inteligência artificial (IA) e líder em aplicativos do mundo real para triagem ocular por IA, anunciou hoje que recebeu a liberação 510 (k) (K200667) pela…
Riassunto: Eyenuk annuncia l’approvazione da parte dell’FDA del suo sistema autonomo AI EyeArt per il rilevamento della retinopatia diabetica
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., fornitore globale di servizi e tecnologie medicali basati sull’intelligenza artificiale (AI), nonché leader nell’applicazione nel mondo reale della tecnologia AI Eye Screening, ha annunciato oggi di aver otten…
COVID-19 Impacts: Ophthalmic Diagnostic Devices Market Will Accelerate at a CAGR of over 6% through 2020-2024 | Increasing Prevalence of Ophthalmic Diseases to Boost Growth | Technavio
LONDON–(BUSINESS WIRE)– #GlobalOphthalmicDiagnosticDevicesMarket–The Global Ophthalmic Diagnostic Devices Market will grow by USD 0.98 bn during 2020-2024
My Eyelab Delivers on 2020 Vision with Impressive YTD Growth
PALM SPRINGS, Fla.–(BUSINESS WIRE)–My Eyelab, a retail brand of Now Optics, is staying true to its vision of modernizing the eye care experience for all people and making franchising easy. 2020 has already proven immense growth for the brand with 23 …
Leo Lens Pharma Expands Its Scientific Advisory Board
SAN DIEGO–(BUSINESS WIRE)–Leo Lens Pharma Expands Its Scientific Advisory Board
Eyenuk Announces FDA Clearance for EyeArt Autonomous AI System for Diabetic Retinopathy Screening
LOS ANGELES–(BUSINESS WIRE)– #FDA–Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, announced today that it has received 510(k) clearance (K200…
World Retinal Biologics Market: Growth, Trends and Forecasts (2020-2025) – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinal Biologics Market – Growth, Trends, and Forecasts (2020-2025)” report has been added to ResearchAndMarkets.com’s offering. The Global Retinal Biologics Market studied is anticipated to grow with a CAGR of nearly 6.8…
IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced Pravin Dugel, MD will present an overview of the Company at the Wedbush PacGrow Healthcare Virtual Conference on Aug. 12, 2020.
Kala Pharmaceuticals to Present at 2020 Wedbush PacGrow Healthcare Virtual Conference
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will present a…
Gyroscope Announces Appointment of Leaders in Retinal Disease, Gene Therapy and the Complement System to Its Clinical and Scientific Advisory Boards
LONDON–(BUSINESS WIRE)–Gyroscope announces appointment of leaders in retinal disease, gene therapy and the complement system to its Clinical and Scientific Advisory Boards.
IVERIC bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
NEW YORK–(BUSINESS WIRE)–IVERIC bio reported that the Company granted Dhaval Desai, Chief of Staff, equity based awards pursuant to the 2019 Inducement Stock Incentive Plan.
National Wildlife Refuge, State Park and City Offer Scenic Viewers Adapted for Color Blindness from EnChroma and SeeCoast
BERKELEY, Calif. & FAIRHOPE, Ala.–(BUSINESS WIRE)– #CityofSandyOR–National Wildlife Refuge in Florida, Georgia State Park and Oregon City to Offer Scenic Viewers Adapted for Color Blindness from EnChroma and SeeCoast
New Topline TEPEZZA® (teprotumumab-trbw) Data Underscore its Efficacy in Longer Disease Duration, Long-Term Durability and Potential for Retreatment in People Living with Thyroid Eye Disease (TED)
DUBLIN–(BUSINESS WIRE)–Horizon announced topline data adding to the growing body of evidence supporting the efficacy and safety of TEPEZZA for Thyroid Eye Disease (TED).
Ocular Therapeutix™ To Report Second Quarter 2020 Financial Results
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix™, Inc. (NASDAQ: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today…
I LED a spettro naturale della serie SunLike di Seoul Semiconductor adottati da un marchio tradizionale giapponese per l’illuminazione delle camerette dei ragazzi per favorire la concentrazione e l’apprendimento degli studenti
ANSAN, Corea del Sud–(BUSINESS WIRE)–Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), importante azienda globale produttrice di semiconduttori compositi, ha reso noto che i propri LED a spettro naturale della serie SunLike sono stati scelti da KOIZUMI …
Les LED à spectre naturel de la série SunLike de Seoul Semiconductor sont adoptées par une marque japonaise traditionnelle pour l’éclairage des chambres d’enfants afin de favoriser l’apprentissage et la concentration des élèves
ANSAN, Corée du Sud–(BUSINESS WIRE)–Seoul Semiconductor Co., Ltd. (KOSDAQ 046890), un leader mondial des semi-conducteurs composites, a annoncé que les diodes électroluminescentes (Light Emitting Diodes, LED) à spectre naturel de sa série SunLike ont…
Lineage Cell Therapeutics to Report Second Quarter 2020 Financial Results and Provide Business Update on August 6, 2020
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that it will report its se…
Aerie Pharmaceuticals to Announce Second Quarter 2020 Financial Results and Host Conference Call on Thursday, August 6, 2020
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…